Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats. 
Home
Equities
ICCC
Chart

Immucell Corp /De/

ICCC

Jan 1 1970 00:00:00
0.00
0.000.00%
0.00
0.00
0.00
0.00
0.00
-0.04000
8.98M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-10-08
Form 8-K
ID: 0001213900-24-086275
2024-09-24
Form 8-K
ID: 0001213900-24-081304
2024-09-24
Form 4
ID: 0001213900-24-081210
2024-09-24
Form 4
ID: 0001213900-24-081209
2024-09-24
Form 4
ID: 0001213900-24-081207
2024-09-24
Form 4
ID: 0001213900-24-081206
2024-09-24
Form 4
ID: 0001213900-24-081205
2024-09-17
SCHEDULE 13D/A
ID: 0001744329-24-000005
2024-08-30
Form 4
ID: 0001213900-24-074326
2024-08-27
Form SC 13D
ID: 0001193125-24-207799

You might find these companies interesting

VRAX
Virax Biolabs Group Ltd
In Vitro & In Vivo Diagnostic Substances (2835)
NYMXF
Nymox Pharmaceutical Corp
In Vitro & In Vivo Diagnostic Substances (2835)
NEOG
Neogen Corp
In Vitro & In Vivo Diagnostic Substances (2835)
BZYR
Burzynski Research Institute Inc
In Vitro & In Vivo Diagnostic Substances (2835)
BMRA
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances (2835)
ABIO
Arca Biopharma, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
TRIB
Trinity Biotech Plc
In Vitro & In Vivo Diagnostic Substances (2835)
QDEL
Quidelortho Corp
In Vitro & In Vivo Diagnostic Substances (2835)
IDXX
Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances (2835)
LNTH
Lantheus Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
MYGN
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances (2835)
ORKA
Oruka Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
ENSC
Ensysce Biosciences, Inc.
Pharmaceutical Preparations (2834)
GLUE
Monte Rosa Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) (2836)